Here's What's Going On With Novavax Shares

Novavax, Inc. NVAX shares are trading lower by 3.05% to $58.43 Monday afternoon in sympathy with BioNTech SE - ADR BNTX, which reported worse-than-expected second-quarter results.

What Happened?

BioNTech believes the development of the pandemic remains dynamic, causing a re-phasing of orders and leading to fluctuations in quarterly revenues. 

This revenue fluctuation caused by the re-phasing of orders is expected to remain over the rest of the financial year with uptake in demand in key markets in fourth-quarter FY22 related to the Omicron-adapted bivalent vaccine, subject to regulatory approval... Read More

According to data from Benzinga Pro, Novavax has a 52-week high of $277.80 and a 52-week low of $34.88.

Loading...
Loading...
NVAX Logo
NVAXNovavax Inc
$6.40-1.55%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
12.27
Growth
Not Available
Quality
Not Available
Value
47.17
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...